DDrare: Database of Drug Development for Rare Diseases

Pyridoxine (DrugBank: Pyridoxine)

3 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	0
93	原発性胆汁性胆管炎［原発性胆汁性肝硬変 (~2017.3)］	1
145	ウエスト症候群	1

6. パーキンソン病　［臨床試験数：2,123，薬物数：2,046（DrugBank：324），標的遺伝子数：183，標的パスウェイ数：198］

Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 2,123 trial found

93. 原発性胆汁性胆管炎［原発性胆汁性肝硬変 (~2017.3)］　［臨床試験数：230，薬物数：215（DrugBank：51），標的遺伝子数：34，標的パスウェイ数：107］

Searched query = "Primary biliary cholangitis", "Primary biliary cirrhosis", "PBC"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 230 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2006-006742-34-GB (EUCTR)	20/12/2007	03/06/2007	The effect of Ezetimibe or pyridoxine in Patients with Primary Biliary Cirrhosis.	The effect of Ezetimibe or pyridoxine in Patients with Primary Biliary Cirrhosis.	primary biliary cirrhosis MedDRA version: 9.1;Level: LLT;Classification code 10036680;Term: Primary biliary cirrhosis		Barts and The London NHS Trust	NULL	Not Recruiting			Female: yes Male: yes	70	Phase 4	United Kingdom

145. ウエスト症候群　［臨床試験数：39，薬物数：50（DrugBank：13），標的遺伝子数：27，標的パスウェイ数：24］

Searched query = "West syndrome", "Infantile spasm"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 39 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01828437 (ClinicalTrials.gov)	November 2012	7/4/2013	Addition of Pyridoxine to Prednisolone in Infantile Spasms	Addition of Pyridoxine to Prednisolone in the Treatment of Infantile Spasms: A Randomized Controlled Trial	Infantile Spasms	Drug: Pyridoxine plus prednisolone;Drug: Prednisolone	Lady Hardinge Medical College	NULL	Completed	3 Months	36 Months	All	62	Phase 3	India